Biotechnology News and Research

RSS

Czura Thornton to acquire MDS's Central Labs operation

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.

From Danaher 9 Oct 2009

International symposium examines how new advances in plant science research can benefit African agriculture

This three-day international symposium is designed to bring together scientists from Africa, Europe and the USA to examine how new advances in plant science research and developing technologies can be used to the benefit of African agriculture

9 Oct 2009

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

9 Oct 2009

Fight against obesity and heart disease gets new boost from public sector and industry

The battle against obesity, heart disease and other diet related health problems received a -4 Million boost today with the announcement of seven new research projects. The projects, taking place in universities and research institutes across the UK, are part of a partnership between two publicly-funded Research Councils and 15 companies.

9 Oct 2009

Plexxikon commences patient dosing in PLX3397 Phase 1 clinical trial

Plexxikon Inc. today announced that dosing of cancer patients with PLX3397 has started in a Phase 1 clinical trial. PLX3397 is a novel, oral investigational drug for treating multiple diseases, including metastatic cancer and rheumatoid arthritis.

9 Oct 2009

NHLBI grants for diagnosis and treatment of cardiovascular and blood disorders

Two teams led by Massachusetts General Hospital (MGH) researchers, also members of the Harvard Stem Cell Institute (HSCI), are among 18 groups receiving National Heart Lung and Blood Institute (NHLBI) grants for the development of stem-cell based tools and treatments to understand and treat cardiovascular and blood disorders.

9 Oct 2009

Pro Lab Marketing receives distribution rights for Vivakor’s VivaThermic cryovials in India

Vivakor, Inc. announces distribution of its VivaThermic products to the rapidly growing biotech/biopharma industries in India through its agreement with Pro Lab Marketing Pvt. Ltd.

9 Oct 2009

HST Global announces alliance for R&D of Nutraceutical and Medical Food formulation platform

HST Global, Inc. today announced a strategic R&D alliance with Dr. James W. Forsythe for the research and development of HST’s exclusive Nutraceutical and Medical Food formulation platform.

9 Oct 2009

U.S. army Phase I STTR contract for Intralytix

Intralytix, Inc. announced today that it has received a U.S. Army Phase I STTR contract supporting the development of a bacteriophage-based probiotic preparation for managing Shigella infections.

9 Oct 2009

CHI announces its agenda for the 2009 California Healthcare Policy Forum

CHI-California Healthcare Institute today announced its agenda and newly confirmed speakers for the 2009 California Healthcare Policy Forum to be held Nov. 5, at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to 6:00 p.m.

9 Oct 2009

Applied Neurosolutions provides update regarding its blood-based Alzheimer’s test

Applied NeuroSolutions, Inc.(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today confirmed, as previously disclosed in July 2009, that it has achieved sufficient analytical sensitivity to detect tau in serum patient samples.

9 Oct 2009

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Transgenomic, Inc. (OTC Bulletin Board: TBIO). The company announced today that it has licensed a high-sensitivity mutation detection technology called Cold-PCR from the Dana-Farber Cancer Institute (DFCI), Boston, MA.

9 Oct 2009

Angiochem to announce clinical study results of ANG1005 drug

Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem’s Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.

8 Oct 2009

Helicos Biosciences awarded a $2.9M NIH grant

Helicos BioSciences Corporation announced today that it is the recipient of an award from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH).

8 Oct 2009

Advanced Health Media acquires marketing services provider Ephikacy

Advanced Health Media, LLC (AHM) has acquired Ephikacy, LLC, the Chicago-based provider of marketing services and related technology for the pharmaceutical and life sciences industries.

8 Oct 2009

Journalists meet to discuss different aspects of biotechnology and its impact on society

More than 90 journalists from all over the world meet in Heidelberg, today, for the 4th Alumni Conference of the International Journalists’ Programmes (IJP). In keynote-speeches, panel discussions and excursions participants will discover different aspects of biotechnology and its impact on society.

8 Oct 2009

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

Waleed Danho, Ph.D., Distinguished Research Leader at Roche was honored last week as the 2009 recipient of the Meienhofer Award for excellence in peptide chemistry at the international peptide symposium, RCCPS (http://www.rochecolorado.com/PeptideSymp09/).

8 Oct 2009

New research report outlines growth prospects of Biomagnetics Diagnostics

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is the subject of a new research report issued by Emerging Growth Research, LLP.

8 Oct 2009

Talecris Biotherapeutics closes initial public offering of common stock

Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) (“Talecris” or the “Company”) today announced the closing on October 6 of its initial public offering of shares of common stock, which was priced on September 30 at a public offering price of $19.00 per share.

8 Oct 2009

Mimetogen Pharmaceuticals completes its equity financing

Mimetogen Pharmaceuticals Inc. ("Mimetogen"), a privately held drug development company announced today that it has successfully completed an equity financing, co-led by Boston-based VIMAC Milestone Medica Fund and Montréal-based iNovia Capital.

8 Oct 2009

Biotechnology News and Research

Czura Thornton to acquire MDS's Central Labs operation

International symposium examines how new advances in plant science research can benefit African agriculture

New York Governor participates in roundtable discussion on stem cell research

Fight against obesity and heart disease gets new boost from public sector and industry

Plexxikon commences patient dosing in PLX3397 Phase 1 clinical trial

NHLBI grants for diagnosis and treatment of cardiovascular and blood disorders

Pro Lab Marketing receives distribution rights for Vivakor’s VivaThermic cryovials in India

HST Global announces alliance for R&D of Nutraceutical and Medical Food formulation platform

U.S. army Phase I STTR contract for Intralytix

CHI announces its agenda for the 2009 California Healthcare Policy Forum

Applied Neurosolutions provides update regarding its blood-based Alzheimer’s test

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Angiochem to announce clinical study results of ANG1005 drug

Helicos Biosciences awarded a $2.9M NIH grant

Advanced Health Media acquires marketing services provider Ephikacy

Journalists meet to discuss different aspects of biotechnology and its impact on society

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

New research report outlines growth prospects of Biomagnetics Diagnostics

Talecris Biotherapeutics closes initial public offering of common stock

Mimetogen Pharmaceuticals completes its equity financing

Biotechnology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News